SecProbe.io

CORRESP
1
filename1.htm

    MediWound Ltd.

    42 Hayarkon Street

    Yavne 8122745, Israel

    November 22, 2022

    VIA EDGAR

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    Office of Life Sciences

    Securities and Exchange Commission

    Washington, D.C. 20549

    Attention: Joshua Gorsky

            Re:

            MediWound Ltd.

            Registration Statement on Form F-1

            Filed November 10, 2022

            File No. 333-268297 (the “Registration Statement”)

    Request for Acceleration

    Ladies and Gentlemen:

    Pursuant to Rule 460 and 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, MediWound Ltd. (the “Company”) hereby respectfully requests acceleration of the effective date of the
      Registration Statement, so that it may become effective at 5:00 p.m., Eastern Time, on November 25, 2022, or as soon thereafter as practicable.

    Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel,
      Michael J. Rosenberg, Esq. of Latham & Watkins LLP at (212) 906-1829.

            Very truly yours,

            MEDIWOUND LTD.

            By:

            /s/ Ofer Gonen

            Ofer Gonen

            Chief Executive Officer

    cc:   Michael J. Rosenberg, Esq., Latham & Watkins LLP